A Methylome Classifier Identifies Patients at Risk for Locoregional Recurrence after Adjuvant Radiochemotherapy in HPV-DNA negative HNSCC: a Multicenter Trial of the German Cancer Consortium- Radiation Oncology Group (DKTK-ROG)

Hypoxia Methylome Classifier (HDMC) Outperforms Gene Signatures in Identifying HPV-Negative HNSCC Patients at Risk for Locoregional Failure Post Primary Radiochemotherapy: A German Cancer Consortium Radiation Oncology Group (DKTK-ROG) Multicenter Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.1715 ◽

2020 ◽

Vol 108 (3) ◽

pp. e552-e553

Author(s):

B. Tawk ◽

U. Wirkner ◽

C. Schwager ◽

E. Herpel ◽

I. Tinhofer ◽

...

Keyword(s):

At Risk ◽

Radiation Oncology ◽

Multicenter Trial ◽

Oncology Group ◽

Gene Signatures ◽

Locoregional Failure ◽

Patients At Risk ◽

Impact of Oncotype DX Recurrence Score on the Patterns of Locoregional Recurrence in Breast Cancer (Korean Radiation Oncology Group 19-06)

Journal of Breast Cancer ◽

10.4048/jbc.2020.23.e36 ◽

2020 ◽

Vol 23 (3) ◽

pp. 314

Author(s):

Kyubo Kim ◽

Jinhong Jung ◽

Kyung Hwan Shin ◽

Jin Ho Kim ◽

Ji Hyun Chang ◽

...

Keyword(s):

Breast Cancer ◽

Radiation Oncology ◽

Locoregional Recurrence ◽

Recurrence Score ◽

Oncotype Dx ◽

Oncology Group ◽

Oncotype Dx Recurrence Score

Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.01.008 ◽

2015 ◽

Vol 92 (1) ◽

pp. 32-39 ◽

Cited By ~ 75

Author(s):

Lena Specht ◽

Bouthaina Dabaja ◽

Tim Illidge ◽

Lynn D. Wilson ◽

Richard T. Hoppe

Keyword(s):

Radiation Therapy ◽

Radiation Oncology ◽

Oncology Group ◽

Cutaneous Lymphomas ◽

Corrigendum to “HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)” [Radiother. Oncol. 113 (2014) 317–323]

Radiotherapy and Oncology ◽

10.1016/j.radonc.2015.03.010 ◽

2015 ◽

Vol 114 (3) ◽

pp. 419

Author(s):

Fabian Lohaus ◽

Annett Linge ◽

Inge Tinhofer ◽

Volker Budach ◽

Eleni Gkika ◽

...

Keyword(s):

Radiation Oncology ◽

Locally Advanced ◽

Oropharyngeal Carcinoma ◽

Oncology Group ◽

Regional Control ◽

Explorative Study ◽

Postoperative Radiochemotherapy

Modern Radiotherapy for Extranodal Nasal-type NK/T-cell Lymphoma: Risk-adapted Therapy, Target Volume and Dose Guidelines from the International Lymphoma Radiation Oncology Group

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2021.02.011 ◽

2021 ◽

Author(s):

Shu-Nan Qi ◽

Ye-Xiong Li ◽

Lena Specht ◽

Masahiko Oguchi ◽

Richard Tsang ◽

...

Keyword(s):

T Cell ◽

Radiation Oncology ◽

Cell Lymphoma ◽

Target Volume ◽

Oncology Group ◽

Nasal Type ◽

Therapy Target ◽

Modern Radiotherapy ◽

Lymphoma Risk

A Randomised Phase III Trial of Palliative Radiotherapy (PRT) versus Concurrent Chemotherapy and PRT (C-PRT) in Patients with Good Performance Status, Locally Advanced or Metastatic NSCLC with symptoms due to intrathoracic disease who are not suitable for radical Chemo-radiotherapy: Results of the Trans-Tasman Radiation Oncology Group (TROG) 11.03 Trial

Practical Radiation Oncology ◽

10.1016/j.prro.2020.11.009 ◽

2020 ◽

Author(s):

M. Lehman ◽

A. Bernard ◽

A. See ◽

M. King ◽

M. Michael

Keyword(s):

Radiation Oncology ◽

Performance Status ◽

Locally Advanced ◽

Palliative Radiotherapy ◽

Concurrent Chemotherapy ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Metastatic Nsclc ◽

Re: Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03 (Journal of Medical Imaging and Radiation Oncology 62 (2018) 412-419)

Journal of Medical Imaging and Radiation Oncology ◽

10.1111/1754-9485.12792 ◽

2018 ◽

Vol 62 (5) ◽

pp. 671-671

Author(s):

Jonathan Pincus

Keyword(s):

Medical Imaging ◽

Cell Carcinoma ◽

Merkel Cell Carcinoma ◽

Radiation Oncology ◽

Fdg Pet ◽

Prospective Analysis ◽

Merkel Cell ◽

Oncology Group ◽

Oncology Group Study ◽

1045 Poster A Trans Tasman Radiation Oncology Group Phase II study of radical chemoradiation in the management of localised muscle invasive TCC of the urinary bladder (TROG 97.01)

Radiotherapy and Oncology ◽

10.1016/s0167-8140(02)83352-7 ◽

2002 ◽

Vol 64 ◽

pp. S305

Keyword(s):

Urinary Bladder ◽

Phase Ii ◽

Radiation Oncology ◽

Phase Ii Study ◽

Oncology Group ◽

Muscle Invasive

Intensity-Modulated Radiotherapy-Based Reirradiation for Head and Neck Cancer: A Multi-institutional Study by Korean Radiation Oncology Group (KROG 1707)

Cancer Research and Treatment ◽

10.4143/crt.2020.310 ◽

2020 ◽

Author(s):

Jeongshim Lee ◽

Tae Hyung Kim ◽

Yeon-Sil Kim ◽

Myungsoo Kim ◽

Jae Won Park ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Radiation Oncology ◽

Intensity Modulated Radiotherapy ◽

Oncology Group ◽

Intensity Modulated ◽

Preliminary Results of a Prospective Study of Dose Reduced Short-Course CHOP followed by Involved Field Radiotherapy for Elder Patients 70 Years Old or More with Localized Aggressive non-Hodgkins Lymphomas (Japan Radiation Oncology Group; JAROG Study)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2005.07.726 ◽

2005 ◽

Vol 63 ◽

pp. S427

Author(s):

N. Shikama ◽

M. Oguchi ◽

Y. Kagami ◽

K. Isobe ◽

K. Nakamura ◽

...

Keyword(s):

Prospective Study ◽

Radiation Oncology ◽

Oncology Group ◽

Preliminary Results ◽

Elder Patients ◽

Short Course ◽

A Prospective Study ◽

Involved Field ◽

Involved Field Radiotherapy